WallStreetZenWallStreetZen

NASDAQ: CRSP
Crispr Therapeutics Ag Stock Ownership - Who owns Crispr Therapeutics Ag?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Crispr Therapeutics Ag insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Naimish PatelChief Medical Officer2026-05-293,786$55.62
$210.58kSell
James R. KasingerGeneral Counsel and Secretary2026-03-233,182$46.78
$148.85kSell
Raju PrasadChief Financial Officer2026-03-233,708$46.78
$173.46kSell
Samarth KulkarniChief Executive Officer2026-03-2310,020$46.78
$468.74kSell
Raju PrasadChief Financial Officer2026-03-165,848$48.26
$282.22kSell
Raju PrasadChief Financial Officer2026-03-164,021$48.26
$194.05kSell
James R. KasingerGeneral Counsel and Secretary2026-03-163,450$48.26
$166.50kSell
Samarth KulkarniChief Executive Officer2026-03-1610,349$48.26
$499.44kSell
Naimish PatelChief Medical Officer2026-03-163,150$48.26
$152.02kSell
Samarth KulkarniChief Executive Officer2026-03-119,798$52.80
$517.33kSell

1 of 4

CRSP insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CRSP insiders and whales buy or sell their stock.

CRSP Shareholders

What type of owners hold Crispr Therapeutics Ag stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ark Investment Management LLC11.73%11,313,623$542.94MInstitution
Celgene Corp8.87%8,557,514$410.68MInsider
Blackrock Inc7.96%7,680,073$368.57MInstitution
Orbis Allan Gray Ltd6.33%6,106,011$293.03MInstitution
Vertex Pharmaceuticals Europe Ltd5.58%5,380,940$258.23MInsider
Simeon George5.45%5,259,390$252.40MInsider
Bayer Global Investments Bv5.29%5,105,330$245.00MInsider
Capital World Investors4.90%4,725,037$226.75MInstitution
State Street Corp4.13%3,982,500$191.12MInstitution
Gsk PLC3.34%3,220,627$154.56MInstitution

1 of 3

CRSP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CRSP69.13%30.87%Net SellingNet Selling
DYN83.36%16.64%Net SellingNet Selling
DFTX63.13%36.87%Net SellingNet Selling
ACAD71.81%28.19%Net SellingNet Selling
CAI41.84%58.16%Net SellingNet Buying
View Top Biotech Stocks

Crispr Therapeutics Ag Stock Ownership FAQ

Who owns Crispr Therapeutics Ag?

Crispr Therapeutics Ag (NASDAQ: CRSP) is owned by 79.98% institutional shareholders, 35.71% Crispr Therapeutics Ag insiders, and 0.00% retail investors. Celgene Corp is the largest individual Crispr Therapeutics Ag shareholder, owning 8.56M shares representing 8.87% of the company. Celgene Corp's Crispr Therapeutics Ag shares are currently valued at $410.68M.

If you're new to stock investing, here's how to buy Crispr Therapeutics Ag stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.